跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
沐舒坦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ambroxol Hydrochloride Injection
Approved
化学药品
Ambroxol Hydrochloride Injection
Boehringer Ingelheim Pharma GmbH & Co. KG
🇨🇳 National Medical Products Administration
Approval Date
Jun 28, 2023
Approval ID
8TEM0hfhcvB
Company
Boehringer Ingelheim Pharma GmbH & Co. KG
Type
化学药品
Approval Details
Approval Id
8TEM0hfhcvB
Approval Number
国药准字HJ20150469
Generic Name
盐酸氨溴索注射液
Generic Name En
Ambroxol Hydrochloride Injection
Trade Name
沐舒坦
Drug Type
化学药品
Dosage Form
注射剂
Strength
2ml:15mg
Reg Date
2023-06-28
Expired Date
2028-06-27
Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 28, 2023
Approval ID
8TEM0hfhcvB
Type
化学药品
Back to NMPA Approvals